Recent Lessons

Show all results for ""

Feature Overview

Ace your exams with our all-in-one platform for creating and sharing quizzes and tests.

Quizzes

Create quizzes and tests automatically from your content using AI.

Flashcards

Automatically turn your notes into digital flashcards.

Share, Export & Embed

Share with classmates or export to Excel and your learning management system.

Stats & Reporting

Auto-grading quizzes and tests with detailed stats and reports.

Mobile Apps

The smarter way to study – wherever you are.

Pricing

Search...

Cardiovascular Outcomes in Obesity without Diabetes Study Insights

10 Questions

1 Views

Cardiovascular Outcomes in Obesity without Diabetes Study Insights

Choose a study mode

Play Quiz

Study Flashcards

Spaced Repetition

Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What was the primary cardiovascular endpoint of the study?

Improvement in insulin sensitivity

Reduction in LDL cholesterol levels

Reduction in overall mortality rate

Time to first occurrence of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke (correct)

What was the mean weight loss observed in the semaglutide group?

5.2%

3.8%

9.4% (correct)

12.1%

What was the design of the trial?

Single-center, open-label, non-randomized

Multicenter, single-blind, non-randomized

Single-center, double-blind, randomized

Multicenter, double-blind, randomized, placebo-controlled (correct)

What did the study emphasize about the specific objectives?

Focus on overweight and obese individuals without diabetes Signup and view all the answers

What did the study mention about the use of semaglutide?

Reducing cardiovascular risk in patients with diabetes Signup and view all the answers

What was the duration of the multicenter, double-blind, randomized, placebo-controlled trial?

12 months Signup and view all the answers

What were the specific secondary endpoints discussed in the study?

Both b and c Signup and view all the answers

What was the mean weight loss observed in the placebo group?

4.2% Signup and view all the answers

What was the focus of the study in terms of the participants' health status?

Overweight and obese individuals with or without diabetes Signup and view all the answers

What did the study emphasize about the use of semaglutide in reducing cardiovascular risk?

It significantly reduced cardiovascular death Signup and view all the answers